Abattis Files Amended and Restated Financial Statements For the Period Ended March 31, 2017 (PR)

0 Responses Abattis News | Financial

Vancouver, British Columbia / Newsfile Corp. / August 9, 2017 Abattis Bioceuticals Corp. (OTCQB: ATTBF) (CSE: ATT) (the “Company” or “Abattis“) announces that, as a result of a review by the British Columbia Securities Commission, we are issuing the following press release to clarify our disclosure. The review identified certain discrepancies in our condensed consolidated […]